PharmaEngine, Inc. (TPEX: 4162)
Taiwan
· Delayed Price · Currency is TWD 99.90
-1.60 (-1.58%)
Nov 15, 2024, 1:30 PM CST
PharmaEngine Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 370.14 | 274.65 | 318.78 | 426.03 | 604.28 | 42.55 | Upgrade
|
| Depreciation & Amortization | 9.22 | 9.02 | 8.61 | 10.26 | 12.56 | 6.71 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -5.53 | -45.46 | -0.83 | - | - | Upgrade
|
| Stock-Based Compensation | 1.61 | 3.38 | 2.37 | 0.09 | -1.06 | 5.84 | Upgrade
|
| Provision & Write-off of Bad Debts | 0 | -0 | 0.01 | -0.22 | - | - | Upgrade
|
| Other Operating Activities | 19.35 | -33.31 | -54.79 | -81.69 | 69.67 | -24.96 | Upgrade
|
| Change in Accounts Receivable | -21.11 | -13.83 | 0.13 | 541.22 | -616.82 | 3.96 | Upgrade
|
| Change in Inventory | 18.43 | 18.47 | -28.94 | 19.31 | -0.62 | -4.56 | Upgrade
|
| Change in Accounts Payable | 5.38 | 5.38 | -2.05 | 8.62 | 12.06 | -20.08 | Upgrade
|
| Change in Other Net Operating Assets | 7.89 | -1.26 | 3.36 | 6.87 | -15.3 | 6.62 | Upgrade
|
| Operating Cash Flow | 410.89 | 256.97 | 202.01 | 929.67 | 64.77 | 16.08 | Upgrade
|
| Operating Cash Flow Growth | 88.67% | 27.20% | -78.27% | 1335.36% | 302.84% | -97.84% | Upgrade
|
| Capital Expenditures | -0.91 | -0.41 | -3.44 | -0.23 | - | -0.21 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.61 | - | -0.5 | - | -0.61 | - | Upgrade
|
| Investment in Securities | -1,214 | -854.48 | -183.98 | -105 | 1,765 | -18.3 | Upgrade
|
| Other Investing Activities | 0.17 | -0.59 | -0.2 | -1.77 | -0.07 | 0.01 | Upgrade
|
| Investing Cash Flow | -1,216 | -855.48 | -188.12 | -107 | 1,764 | -18.5 | Upgrade
|
| Long-Term Debt Repaid | - | -7.54 | -8 | -9.6 | -10.82 | -3.69 | Upgrade
|
| Net Debt Issued (Repaid) | -7.63 | -7.54 | -8 | -9.6 | -10.82 | -3.69 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 11.9 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -133.41 | -3.84 | -125.52 | Upgrade
|
| Common Dividends Paid | -215.44 | -287.19 | -387.71 | -363.99 | -72.83 | -145.67 | Upgrade
|
| Financing Cash Flow | -223.08 | -294.73 | -395.71 | -507 | -87.5 | -262.98 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | -0.75 | 1.56 | -0.17 | Upgrade
|
| Net Cash Flow | -1,028 | -893.24 | -381.81 | 314.93 | 1,743 | -265.58 | Upgrade
|
| Free Cash Flow | 409.98 | 256.56 | 198.57 | 929.44 | 64.77 | 15.87 | Upgrade
|
| Free Cash Flow Growth | 88.62% | 29.20% | -78.64% | 1335.01% | 308.12% | -97.87% | Upgrade
|
| Free Cash Flow Margin | 49.28% | 33.42% | 30.34% | 141.94% | 6.13% | 5.05% | Upgrade
|
| Free Cash Flow Per Share | 2.85 | 1.78 | 1.38 | 6.42 | 0.44 | 0.11 | Upgrade
|
| Cash Interest Paid | 0.21 | 0.31 | 0.08 | 0.21 | 0.44 | 0.11 | Upgrade
|
| Cash Income Tax Paid | 56.21 | 92.35 | 124.42 | 200.65 | 99.35 | 28.09 | Upgrade
|
| Levered Free Cash Flow | 285.3 | 159.87 | 105.29 | 723.9 | -50.51 | 1.99 | Upgrade
|
| Unlevered Free Cash Flow | 285.44 | 160.06 | 105.34 | 724.04 | -50.23 | 2.06 | Upgrade
|
| Change in Net Working Capital | -30.66 | 25.17 | 78.41 | -487.23 | 567.19 | 30.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.